Showing results (11-20 of 648) with videos related to
Sort By:
Pageof 65
Drug News & Perspectives|August 26, 2003
HIV-1 NCp7 as a target for the design of novel antiviral agentsS Druillennec, B P RoquesComptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1992
[Selective opioid agonists and inhibitors of enkephalin degradation enzymes: pharmacological and clinical values]F Noble, B P RoquesEuropean Journal of Biochemistry|November 24, 1999
NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein VprK Wecker, B P RoquesTrends in Pharmacological Sciences|June 1, 1990
Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives?B P Roques, A BeaumontAnnales De Medecine Interne|February 5, 2004
[Doping: health risks and relation to addictive behaviors]Françoise Siri, Bernard P RoquesNeuroscience Letters|February 9, 1995
Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphineF Noble, B P RoquesExpert Opinion on Therapeutic Targets|January 18, 2007
Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugsFlorence Noble, Bernard P RoquesNeuroscience Letters|May 13, 1998
Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in ratsO Valverde, B P RoquesFEBS Letters|January 20, 1997
Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in miceF Noble, B P RoquesDrugs of Today (Barcelona, Spain : 1998)|January 1, 2004
The role of CCK2 receptors in the homeostasis of the opioid systemFlorence Noble, Bernard P RoquesPageof 65